Andrew Plump

Track

Insider profile

Andrew Plump's trades of Takeda Pharmaceutical Co Ltd's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
16.75
Quantity 179,239
Value US$3,002,258
Transaction date
Proposed sale
Price
15.42
Quantity 169,313
Value US$2,610,806
Transaction date
Proposed sale
Price
13.18
Quantity 121,125
Value US$1,596,428
Transaction date
Proposed sale
Price
15.48
Quantity 138,264
Value US$2,140,334
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-03 2026-09-02
PlS Planned sale
68,583 +3.6%
250.92
US$3,511,874 		68,583 +3.6% 250.92 US$3,511,874
2026-09-02 2026-09-02
PrS Proposed sale
17,386
294.39
US$2,386,153 		17,386 294.39 US$2,386,153
2026-08-21 2026-08-19
PlS Planned sale
44,695 -3.9%
454.98
US$2,755,004 		44,695 -3.9% 454.98 US$2,755,004
2026-08-19 2026-08-19
PrS Proposed sale
19,651
18.49
US$363,348 		19,651 18.49 US$363,348
2026-08-12 2026-08-10
S Sale
165,393 -17.7%
17.10
US$2,828,220 		165,393 -17.7% 17.10 US$2,828,220
2026-07-13 2026-07-13
PrS Proposed sale
179,239
16.75
US$3,002,258 		179,239 16.75 US$3,002,258
2025-07-09 2025-07-09
PrS Proposed sale
169,313
15.42
US$2,610,806 		169,313 15.42 US$2,610,806
2024-07-10 2024-07-11
PrS Proposed sale
121,125
13.18
US$1,596,428 		121,125 13.18 US$1,596,428
2023-07-10 2023-07-11
PrS Proposed sale
138,264
15.48
US$2,140,334 		138,264 15.48 US$2,140,334